Show simple item record

dc.contributor.authorGómez Zorita, Saioa
dc.contributor.authorGonzález Arceo, Maitane
dc.contributor.authorFernández Quintela, Alfredo ORCID
dc.contributor.authorEseberri Barace, Itziar ORCID
dc.contributor.authorTrepiana Arin, Jenifer ORCID
dc.contributor.authorPortillo Baquedano, María Puy ORCID
dc.date.accessioned2021-01-11T10:55:26Z
dc.date.available2021-01-11T10:55:26Z
dc.date.issued2020-12-17
dc.identifier.citationNutrients 12(12) : (2020) // Article ID 3853es_ES
dc.identifier.issn2072-6643
dc.identifier.urihttp://hdl.handle.net/10810/49671
dc.description.abstractIsoflavones are phenolic compounds with a chemical structure similar to that of estradiol. They are present in several vegetables, mainly in legumes such as soy, white and red clover, alfalfa and beans. The most significant food source of isoflavones in humans is soy-derived products. Isoflavones could be used as an alternative therapy for pathologies dependent on hormonal disorders such as breast and prostate cancer, cardiovascular diseases, as well as to minimize menopausal symptoms. According to the results gathered in the present review, it can be stated that there is scientific evidence showing the beneficial effect of isoflavones on bone health and thus in the prevention and treatment of osteoporosis on postmenopausal women, although the results do not seem entirely conclusive as there are discrepancies among the studies, probably related to their experimental designs. For this reason, the results should be interpreted with caution, and more randomized clinical trials are required. By contrast, it seems that soy isoflavones do not lead to a meaningful protective effect on cardiovascular risk. Regarding cancer, scientific evidence suggests that isoflavones could be useful in reducing the risk of suffering some types of cancer, such as breast and endometrial cancer, but further studies are needed to confirm these results. Finally, isoflavones could be useful in reducing hot flushes associated with menopause. However, a limitation in this field is that there is still a great heterogeneity among studies. Lastly, with regard to isoflavone consumption safety, it seems that they are safe and that the most common adverse effect is mild and occurs at the gastrointestinal level.es_ES
dc.description.sponsorshipThis study was supported by Instituto de Salud Carlos III (CIBERobn) under Grant CB12/03/30007, Basque Government under Grant PA20/04 and the University of the Basque Country under Grant GIU18-173es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.subjectisoflavoneses_ES
dc.subjectflavonoidses_ES
dc.subjectphytoestrogenses_ES
dc.subjectsoyes_ES
dc.subjectbone healthes_ES
dc.subjectcardiovascular riskes_ES
dc.subjectcanceres_ES
dc.subjectmenopausal symptomses_ES
dc.titleScientific Evidence Supporting the Beneficial Effects of Isoflavones on Human Healthes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2020-12-24T15:55:44Z
dc.rights.holder2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/2072-6643/12/12/3853/htmes_ES
dc.identifier.doi10.3390/nu12123853
dc.departamentoesFarmacia y ciencias de los alimentos
dc.departamentoeuFarmazia eta elikagaien zientziak


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).